Correlation Between Microsoft and BriaCell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Microsoft and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Microsoft and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and BriaCell Therapeutics.
Diversification Opportunities for Microsoft and BriaCell Therapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Microsoft and BriaCell is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and BriaCell Therapeutics go up and down completely randomly.
Pair Corralation between Microsoft and BriaCell Therapeutics
Given the investment horizon of 90 days Microsoft is expected to under-perform the BriaCell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 5.38 times less risky than BriaCell Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The BriaCell Therapeutics Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 32.00 in BriaCell Therapeutics Corp on August 30, 2024 and sell it today you would earn a total of 2.50 from holding BriaCell Therapeutics Corp or generate 7.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Microsoft vs. BriaCell Therapeutics Corp
Performance |
| Timeline |
| Microsoft |
| BriaCell Therapeutics |
Microsoft and BriaCell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and BriaCell Therapeutics
The main advantage of trading using opposite Microsoft and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| BriaCell Therapeutics vs. Bright Minds Biosciences | BriaCell Therapeutics vs. HP Inc | BriaCell Therapeutics vs. Intel | BriaCell Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |